In the last 3 years, 1315 Capital has acquired 3 companies. It has also invested in 1 other.
1315 Capital’s most common sectors for investment are life science (38%) and medical products (38%). The Firm’s most common investment types include venture (50%) and divestiture (25%). In total, 1315 Capital has invested in 6 US states.
Join Mergr to view 1315 Capital’s full profile and discover more small private equity firms just like it.
1315 Capital is a private investment firm that provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare service companies. The Firm will consider opportunities across the US and generally looks to commit $10 to $30 million per investment. 1315 Capital was formed in 2014 and is based in Philadelphia, Pennsylvania.
Join Mergr to view the latest updates and news from 1315 Capital.
We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.
Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.
Try us for 1 week free today!
No obligation. Cancel anytime.